MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Presbyopia-Correcting Intraocular Lenses (IOLs)

Phase 4
Completed
Conditions
Cataract
Interventions
Device: ReSTOR +3
Device: Crystalens HD
Device: Crystalens AO
First Posted Date
2009-08-21
Last Posted Date
2011-08-09
Lead Sponsor
Alcon Research
Target Recruit Count
132
Registration Number
NCT00963560
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination

First Posted Date
2009-08-19
Last Posted Date
2013-07-04
Lead Sponsor
Alcon Research
Target Recruit Count
195
Registration Number
NCT00961649

Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Systane® Ultra
First Posted Date
2009-07-27
Last Posted Date
2016-11-18
Lead Sponsor
Alcon Research
Target Recruit Count
19
Registration Number
NCT00946777

Subjective and Conjunctival Response to Edge Design of Different Silicone Hydrogels

Not Applicable
Completed
Conditions
Contact Lenses
Interventions
Device: Lotrafilcon B contact lens (Air Optix)
Device: Balafilcon A contact lens (PureVision)
Device: Senofilcon A contact lens (Acuvue Oasys)
Device: Etafilcon A contact lens (Acuvue 2)
Device: Comfilcon A contact lens (Biofinity)
Device: Contact lens care system (EasySept)
First Posted Date
2009-07-16
Last Posted Date
2016-11-16
Lead Sponsor
Alcon Research
Target Recruit Count
30
Registration Number
NCT00940459
Locations
🇬🇧

Optometric Technology Group Ltd, London, United Kingdom

Macular Edema Incidence/Severity Reduction With Nevanac

First Posted Date
2009-07-14
Last Posted Date
2012-10-23
Lead Sponsor
Alcon Research
Target Recruit Count
175
Registration Number
NCT00939276
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Not Applicable
Completed
Conditions
Dry Eye Symptoms
Visual Performance
Interventions
Other: Systane® Ultra
First Posted Date
2009-07-14
Last Posted Date
2012-02-09
Lead Sponsor
Alcon Research
Target Recruit Count
16
Registration Number
NCT00938951

Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL

Phase 4
Completed
Conditions
Cataract
Interventions
Device: AcrySof® ReSTOR® Aspheric IOL
First Posted Date
2009-07-08
Last Posted Date
2010-05-06
Lead Sponsor
Alcon Research
Target Recruit Count
76
Registration Number
NCT00934622
Locations
🇺🇸

Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Acute Clinical Evaluation of Multi-purpose Solutions (MPS) in Soft Contact Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Contact lens multi-purpose solution
Other: Saline/blister pack solution
Device: Contact lenses
First Posted Date
2009-06-29
Last Posted Date
2012-09-10
Lead Sponsor
Alcon Research
Target Recruit Count
278
Registration Number
NCT00929487
Locations
🇬🇧

Visioncare Research, Ltd., Farnham, Surrey, United Kingdom

Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients

Phase 4
Withdrawn
Conditions
Cataracts
Interventions
Device: Toric
Procedure: Limbal Relaxing Incision
First Posted Date
2009-06-29
Last Posted Date
2012-04-12
Lead Sponsor
Alcon Research
Registration Number
NCT00929747
Locations
🇺🇸

Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase 3
Completed
Conditions
Open-angle Glaucoma
Ocular Hypertension
Interventions
Drug: Travoprost/Timolol Maleate Fixed Combination solution
First Posted Date
2009-06-26
Last Posted Date
2014-07-18
Lead Sponsor
Alcon Research
Target Recruit Count
155
Registration Number
NCT00928590
© Copyright 2025. All Rights Reserved by MedPath